QR kód

Gliclazide challenge testing as an alternative diagnostic tool for hepatocyte nuclear factor-1-alpha maturity onset diabetes of the young

Background: Hepatocyte nuclear factor-1-alpha monogenic diabetes (HNF1-alpha DM), formerly known as maturity-onset diabetes of the young type 3 (MODY 3), is often misdiagnosed as type 1 or type 2 diabetes. In regions where genetic testing is unavailable, alternative diagnostic approaches are needed....

Celý popis

Uloženo v:
Hlavní autoři: Sunjay Pandya, Rutbah Khairati, Jesheen Mann, Lucy Archer, Ponnusamy Saravanan, Fernando Erneta III, Vinod Patel
Médium: Artigo
Jazyk:Inglês
Vydáno: SMC MEDIA SRL 2025-12-01
Edice:European Journal of Case Reports in Internal Medicine
Témata:
maturity-onset diabetes of the young (mody)
monogenic diabetes
hnf1a mutation
gliclazide
c-peptide
On-line přístup:https://www.ejcrim.com/index.php/EJCRIM/article/view/5892
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Podobné jednotky